Melanie Fan
Ampersand Capital Partners
Partner
Boston, Massachusetts

()

Category: Mid/Large Cap
Mark: A

Comments are closed.

Biography

Melanie Fan is a Partner at Ampersand Capital Partners, where she has been a key driver of value creation across the firm’s healthcare and life sciences portfolio since joining in 2018. Known for her strategic rigor and hands-on operating approach, Melanie partners closely with management teams to execute complex transformations and scale high-growth businesses in regulated markets.


In 2024, Melanie completed the carve-out and platform investment of Gannet BioChem, a specialty chemical CDMO spun out of Nektar Therapeutics. She has also played central roles in building and scaling multiple Ampersand portfolio companies, including StageBio, Vantage MedTech, and Resolian. Her past and current board roles include AnaBios, Gannet BioChem, LakePharma, Resolian, StageBio, and Vantage MedTech.


Prior to Ampersand, she worked at Frazier Healthcare and UBS Investment Bank. Melanie holds a BS in economics and statistics from Duke University and an MBA from Wharton.


Awards

Top Women Leaders in Growth Investing: 2026

Top 40 Under 40 Growth Investors: 2025